SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-320975
Filing Date
2021-11-05
Accepted
2021-11-05 07:59:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d244689ds3.htm S-3 308635
2 EX-4.6 d244689dex46.htm EX-4.6 289853
3 EX-5.1 d244689dex51.htm EX-5.1 24367
4 EX-23.1 d244689dex231.htm EX-23.1 1460
5 GRAPHIC g244689g1030133122358.jpg GRAPHIC 3252
6 GRAPHIC g244689g1030133122624.jpg GRAPHIC 1414
7 GRAPHIC g244689g54g56.jpg GRAPHIC 42646
  Complete submission text file 0001193125-21-320975.txt   686443
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260799 | Film No.: 211382370
SIC: 2834 Pharmaceutical Preparations